886579-13-1

886579-13-1 structure
886579-13-1 structure

Name N-[(3-endo)-8-{(2S)-2-Hydroxy-3-[4-(methylsulfonyl)-1-piperazinyl ]propyl}-8-azabicyclo[3.2.1]oct-3-yl]-1-isopropyl-2-oxo-1,2-dihyd ro-3-quinolinecarboxamide
Molecular Formula C28H41N5O5S
Molecular Weight 559.72100
Exact Mass 559.28300
PSA 127.06000
LogP 2.71500

~%

886579-13-1 structure

886579-13-1

Literature: THERAVANCE, INC. Patent: US2006/100426 A1, 2006 ; Location in patent: Page/Page column 21 ; US 20060100426 A1

~75%

886579-13-1 structure

886579-13-1

Literature: McKinnell, R. Murray; Armstrong, Scott R.; Beattie, David T.; Choi, Seok-Ki; Fatheree, Paul R.; Gendron, Roland A. L.; Goldblum, Adam; Humphrey, Patrick P.; Long, Daniel D.; Marquess, Daniel G.; Shaw; Smith, Jacqueline A. M.; Turner, S. Derek; Vickery, Ross G. Journal of Medicinal Chemistry, 2009 , vol. 52, # 17 p. 5330 - 5343
Precursor  1

DownStream  0